<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Seattle Genetics Inc. | Company News & Executive Profiles - SGEN | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/seattle+genetics+inc..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Seattle Genetics Inc.]]></description>
	<s:counts start="0" returned="10" found="12" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Seattle Genetics Inc. Q2 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-324152.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions. Our first question comes from the line of Cory Kasimov with JPMorgan. Please go ahead. Mona Ashiya - JPMorgan Hi, good afternoon. This is actually Mona for Cory. Congratulations on the progress. I had a couple of questions. One is, now that the enrolment with...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 23 Jul 2009 18:49:27 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/j.p.+morgan+chase+%2526+co..html"><![CDATA[J.P. Morgan Chase & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/seattle+genetics+inc..html"><![CDATA[Seattle Genetics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/business+structures.html"><![CDATA[Business Structures]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">JPM</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SGEN</category>
		<category domain="tickers">JPM,SGEN</category>
	</item>
	<item>
		<title><![CDATA[Seattle Genetics Inc. Q2 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F151006-seattle-genetics-inc-q2-2009-earnings-call-transcript%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Seattle Genetics Inc. SGEN   Q2 2009 Earnings Call   July 23, 2009 17:00 pm ET]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 23 Jul 2009 07:49:27 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/seattle+genetics+inc..html"><![CDATA[Seattle Genetics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SGEN</category>
		<category domain="tickers">SGEN</category>
	</item>
	<item>
		<title><![CDATA[Seattle Genetics Inc. Q1 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-291554.html]]></link>
		<description><![CDATA[ Earnings Call ExcerptSeattle Genetics Inc. SGEN Q1 2009 Earnings Call April 23, 2009 05:00 pm ET Executives Peggy Pinkston - Director of Corporate Communications Clay Siegall - President and CEO Todd Simpson - CFO Tom Reynolds - CMO Eric Dobmeier - CBO  Analysts  Mark Monane - Needham...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 23 Apr 2009 18:12:33 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/adc+telecommunications+inc..html"><![CDATA[ADC Telecommunications Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/financial.html"><![CDATA[Financial]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/conference+call.html"><![CDATA[Conference Call]]></category>
		<category domain="http://resources.bnet.com/topic/seattle+genetics+inc..html"><![CDATA[Seattle Genetics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/financial+accounting.html"><![CDATA[Financial Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ADCT</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SGEN</category>
		<category domain="tickers">ADCT,SGEN</category>
	</item>
	<item>
		<title><![CDATA[Seattle Genetics, Inc. Q4 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-268080.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator instructions And our first question comes from the line of Cory Kasimov with JPMorgan. Please go ahead. Mona Ashiya &#8211; JPMorgan Good afternoon. Actually, this is Mona for Cory. A couple of questions. One relates to SGN-35 and I wonder if you could speak a bit...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 11 Feb 2009 18:08:09 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/response.html"><![CDATA[Response]]></category>
		<category domain="http://resources.bnet.com/topic/bar.html"><![CDATA[Bar]]></category>
		<category domain="http://resources.bnet.com/topic/j.p.+morgan+chase+%2526+co..html"><![CDATA[J.P. Morgan Chase & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/seattle+genetics+inc..html"><![CDATA[Seattle Genetics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">JPM</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SGEN</category>
		<category domain="tickers">JPM,SGEN</category>
	</item>
	<item>
		<title><![CDATA[Rigel and Seattle Genetics: The Delicate Art of Expectation Management]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F119415-rigel-and-seattle-genetics-the-delicate-art-of-expectation-management%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Ohad Hammer submits: In my previous article, I discussed the pharmaceutical industry&#8217;s race after approved drugs and late stage agents with proof of concept in humans. I mentioned Rigel&#8217;s RIGL lead drug, R788, as a likely target for collaboration due to its impressive activity, the huge addressable market and the...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 09 Feb 2009 12:29:47 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/ohad+hammer.html"><![CDATA[Ohad Hammer]]></category>
		<category domain="http://resources.bnet.com/topic/rigel+pharmaceuticals+inc..html"><![CDATA[Rigel Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/seattle+genetics+inc..html"><![CDATA[Seattle Genetics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RIGL</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SGEN</category>
		<category domain="tickers">RIGL,SGEN</category>
	</item>
	<item>
		<title><![CDATA[Seattle Genetics, Inc. Q3 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-243688.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator  Thank you. Operator instructions Our first question comes from the line of Mark Monane with Needham & Company. Please go ahead. Mark Monane &#8211; Needham & Company  Good afternoon. Greetings from New York City. And thanks for reviewing the very busy third quarter. A couple...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 24 Oct 2008 05:24:09 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[Patient]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/payload.html"><![CDATA[Payload]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/seattle+genetics+inc..html"><![CDATA[Seattle Genetics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[Patient]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/payload.html"><![CDATA[Payload]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/seattle+genetics+inc..html"><![CDATA[Seattle Genetics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SGEN</category>
		<category domain="tickers">SGEN</category>
	</item>
	<item>
		<title><![CDATA[My Model Biotech Picks: What's Hot and What's Not]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F90661-my-model-biotech-picks-what-s-hot-and-what-s-not%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[A. Reza Saadat submits:  Analyzing the performance of my previous picks is by far my favorite part of writing this blog. It has on many occasions allowed be to learn from my mistakes.I have moved the numbers to Google docs so that they are easier to read. Here is...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 13 Aug 2008 12:36:18 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/alnylam+pharmaceuticals+inc..html"><![CDATA[Alnylam Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/amgen+inc..html"><![CDATA[Amgen Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/amylin+pharmaceuticals+inc..html"><![CDATA[Amylin Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/celgene+corp..html"><![CDATA[Celgene Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/rigel+pharmaceuticals+inc..html"><![CDATA[Rigel Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/seattle+genetics+inc..html"><![CDATA[Seattle Genetics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ALNY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMGN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMLN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CELG</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RIGL</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SGEN</category>
		<category domain="tickers">ALNY,AMGN,AMLN,CELG,RIGL,SGEN</category>
	</item>
	<item>
		<title><![CDATA[Genentech?s New ADC Platform Has Much Potential, but Is Yet to Be Tested on Humans]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F89380-genentechs-new-adc-platform-has-much-potential-but-is-yet-to-be-tested-on-humans%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Ohad Hammer submits: On June 18th, Seattle Genetics SGEN announced it had received a milestone payment from Genentech DNA after the latter filed an IND Investigational New Drug application for an antibody-drug conjugate [ADC] powered by Seattle Genetics&#8217; technology.  Intriguingly, there was no additional data about the new agent, nor...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 06 Aug 2008 02:46:05 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/genentech+inc..html"><![CDATA[Genentech Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/immunogen+inc..html"><![CDATA[ImmunoGen Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/seattle+genetics+inc..html"><![CDATA[Seattle Genetics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DNA</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IMGN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SGEN</category>
		<category domain="tickers">DNA,IMGN,SGEN</category>
	</item>
	<item>
		<title><![CDATA[Seattle Genetics Inc. Q2 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-225686.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Thank you. We will now begin the Question and Answer session. Operator Instructions. Our first question comes from the line of Mark Monane from Needham. Please go ahead. Mark Monane - Needham Good afternoon and greetings from New York City. A very hot day in New York...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 22 Jul 2008 16:56:07 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/seattle+genetics+inc..html"><![CDATA[Seattle Genetics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SGEN</category>
		<category domain="tickers">SGEN</category>
	</item>
	<item>
		<title><![CDATA[Seattle Genetics Inc. Q1 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-228100.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator instructions Our first question comes from the line of Glenn from Needham & Company. Glenn - Needham & Company Hi, good afternoon.  Congratulations on progress with all of your programs.  I have a question about SGN-33 in the AML program, in the elderly AML...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 24 Apr 2008 20:21:07 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/seattle+genetics+inc..html"><![CDATA[Seattle Genetics Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SGEN</category>
		<category domain="tickers">SGEN</category>
	</item>
</channel>
</rss>
